RACHEL AMIN: Open Payments
NPI 1588369334 · SAINT JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 10 payments from 9 companies in 2025. Trend: 2023 $231 · 2024 $291 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $138 |
| Madrigal Pharmaceuticals | 1 | $125 |
| ABBVIE INC. | 1 | $122 |
| Becton, Dickinson and Company | 1 | $43 |
| Medtronic, Inc. | 1 | $31 |
| GENZYME CORPORATION | 1 | $26 |
| Route 92 Medical, Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Amneal Pharmaceuticals LLC | 1 | $22 |
Products named: REZDIFFRA, BREZTRI, HemoSphere, KYPHON EXPRESS II KYPHOPAK TRAY, JYNARQUE, CREXONT, LOKELMA.
Industry payments across MO — which companies pay providers there.
